Skip to content
value.today

Paragon Therapeutics, Inc.

Total raised
$10 M
1 round on record
Latest round
$10 M
Apr 2021
First round on record
Apr 2021
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Paragon Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2021$10 MNo. 1$10 to $50 million

Paragon Therapeutics, Inc.: Raise no. 1, Apr 2021

Investors in this round

2 investors had bought by the notice of May 10, 2021: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Evan Thompson · Executive Officer, Promoter
  • Peter Harwin · Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Evan Thompson, President. Newest notice filed May 10, 2021. Read the notice at the SEC.

equity, optionsSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Paragon Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (May 2021).

    SEC Form D · May 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2021

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Paragon Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Paragon Therapeutics, Inc.
NameRoleNamed in
Evan ThompsonExecutive officerMay 2021
Peter HarwinDirectorMay 2021
Evan ThompsonPromoterMay 2021
Peter HarwinPromoterMay 2021